Navigation Links
Long Handle Curettes

ProductsLong Handle Curettes
Company Life Instrument Corporation
Item Long Handle Curettes
Features 
Description 15" overall length, 9" handle.
Info Life Instrument Corporation
Customer Service: (800) 925-2995
Web site: http://www.lifeinstruments.com/

Related medicine products :

1. Universal Handle for Blades
2. Universal Trephine Handle with Cottingham Punch
3. Storz Universal Trephine Handle
4. Handle for Corneal Burrs
5. Replacement Handle
6. Thorton Fixation Ring with Handle
7. Full Handle Laseredge Stab Blade Knife, 15 blade
8. Full Handle Laseredge Stab Blade Knife, 15 blade, 3 mm
9. Full Handle Laseredge Stab Blade Knife, 22.5 blade
10. Full Handle Laseredge Stab Blade Knife, 45 blade
11. Full Handle Laseredge Stab Blade Knife, 30 blade
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
Medicine Products:
(Date:8/7/2008)...- Testing men for elevated levels of prostate-spec...rd screening test for prostate cancer -- may be bi...e deceptively low. And this bias may be creating ...ying diagnosis, according to a new study led by in...rham Veterans Affairs (VA) Medical Center. , "W...
(Date:8/7/2008)...oesn,t require fasting, could ID millions who don,...Aug. 7 (HealthDay News) -- A widely used test to m...could help identify millions of people with undete...released by a team of experts. , The hemoglobi...d cells have been exposed to in the previous 120 d...
(Date:8/7/2008)..., Md., Aug. 7 /PRNewswire-USNewswire/ -- Vapotherm...oducts, has received 510(k),clearance from the Foo...(TM), the first high flow humidification system to...cation technology into one device for,the optimal ...her Vapotherm products are currently used in neona...
(Date:8/7/2008)...rves Beneficiary Access to High Quality Nursing Ho... Staffing Efforts, JOPLIN, Mo., Aug. 7 /PRNewswir... protecting the nation,s critical frontline-caregi...r Care (CPSC) today thanked,Senator Pat Roberts fo...in,Congress to stop the Bush Administration from m...
Breaking Medicine News(10 mins):Health News:PSA screening may be biased against obese men, leading to more aggressive cancers 2Health News:Blood Sugar Test May Also Aid Diabetes Detection 2Health News:Vapotherm(R) Precision Flow(TM) Receives FDA 510(k) Clearance 2Health News:Senator Pat Roberts Praised for Leading Successful Effort to Derail $6.2 Million Kansas Medicare Cuts 2
...ce the highest odds for depression, followed by ex...searchers added that more studies are needed befor...dy of cross-sectional data obtained from the US Na...rom different respondents each year from 1994 to 1...
...f Texas has found a gene mutation in people with a... absorb too much calcium. They reported on six gen...es, because they cause too much calcium absorption...a (AH). They also added that people with kidney st...
... of Human Services at the University of Virginia, ...f abdominal visceral fat are associated with unfav...oteins. Abdominal fat was also found to be a prima...n these individuals. The investigators assessed// ...
...ding to earlier studies, is three times higher for... hospitals are even higher. However, a new effort ...e Agency for Healthcare Research and Quality (AHRQ...hildren.// The effort, an educational campaign is ...
Other Medicine News:
(Date:8/7/2008)...e Decision to Expand its Proprietary ...land, Aug. 7 /- ESBATech AG, a leadin...ay announced that the,company has raised an additi...ies B venture round to expand its development pipe...icipated in this round including SV Life,Sciences,...
(Date:8/6/2008)...anently implanted into the heart works,with an ele... patient,s,pulmonary artery pressure, CHICAGO, Au...rtness of,breath are common symptoms that send ten... U.S. hospitals each month. Cardiologists at the B...rial Hospital may be able to,curb such visits for ...
(Date:8/6/2008)...e-FirstCall/ -- GlaxoSmithKline (NYSE:,GSK) (GSK) ...,600 patients,in 54 clinical studies showed no inc...th the anti-HIV medication abacavir. GSK conducted...taken by the D:A:D cohort had found an,unexpected ...tiretroviral,therapy (HAART) regimens containing a...
(Date:8/6/2008)... $15 million payment from collaborator ..., Aug. 6 /- Tolerx, Inc., a,biopharma...lopment of novel,therapies for immune-mediated dis... Phase 3 clinical trial that is evaluating otelixi...a result of the initiation of,patient dosing in DE...
Breaking Medicine Technology:ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing 2ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing 3New Implant Device Remotely Monitors Heart Failure Patients at Northwestern Memorial's Bluhm Cardiovascular Institute 2New Implant Device Remotely Monitors Heart Failure Patients at Northwestern Memorial's Bluhm Cardiovascular Institute 3Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 2Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 3Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 4Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 5Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial 2Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial 3Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial 4Scientists find mercury threatens next generation of loons 13432 1Scientists find mercury threatens next generation of loons 13432 2Hospital Testing for Drug Resistant Infections Dramatically Lowers Mortality Rates and Costs 13429 1Hospital Testing for Drug Resistant Infections Dramatically Lowers Mortality Rates and Costs 13429 2Troubled Boys Will Abandon Pot When Its Deemed Uncool 13426 1Troubled Boys Will Abandon Pot When Its Deemed Uncool 13426 2Imports from Latin America may help US meet energy goals study finds 2400 1Imports from Latin America may help US meet energy goals study finds 2400 2Imports from Latin America may help US meet energy goals study finds 2400 3
...USINESS WIRE)--Jun 13, 2007 - EPIX,Pharmaceuticals...om,its Phase 3 trial of PRX-00023, a novel long-ac...entation at the 47th Annual New,Clinical Drug Eval.... The meeting is sponsored by the National Institu... Psychopharmacology., The presentation highlighted...
...--(BUSINESS WIRE)--Jun 14, 2007 - Can-Fite,BioPhar...the Tel,Aviv Stock Exchange Exchange, proceeds wit... in addition to CF101, which is currently,in clini...es. This,weekend Can-Fite will present at the EUAL...vivo study results showing effective,anti-inflamma...
Other Medicine Technology:EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 2EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 3EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 4Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology 2